✓ checked
trust me, bro:
here is the receipt.
the claim
STAT reported that Merck is discontinuing a crucial antibiotic despite concerns about antibiotic-resistant bacteria.
the verdict
INSUFFICIENT LEANING
Recorded sources
0 sources for · 2 against
Is it true that STAT reported that Merck is discontinuing a crucial antibiotic despite concerns about antibiotic-resistant bacteria?
Unclear. The retrieved items do not address the claim that STAT reported Merck discontinuing a crucial antibiotic over resistance concerns. Two items describe Merck's 2004 worldwide withdrawal of the arthritis drug Vioxx for cardiovascular risk, which is a different drug and a different reason, so they only partially bear on the claim.
Verdict: PARTIAL LEAN · 0 sources for, 2 against · Last checked
Evidence against · 2
Get citation
Merck withdraws arthritis drug worldwide - PMC Lock. (n.d.). pmc.ncbi.nlm.nih.gov. https://doi.org/10.1136/bmj.329.7470.816-a
See more details
More against · 1
Get citation
Professionalism/Vioxx: Merck and the FDA. (n.d.). en.wikibooks.org. https://en.wikibooks.org/wiki/Professionalism/Vioxx:_Merck_and_the_FDA
Receipt History
Anyone with this link can read the claim and its public receipt, including any
personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check
or guarantee a response time.
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work
Terms · Privacy · How verdicts work